RSS   Newsletter   Contact   Advertise with us
Post Online Media

KalVista Pharma appoints Edward P. Feener as CSO

KalVista PharmaceuticalsKalVista Pharmaceuticals, a pharmaceutical company, announced the appointment of Edward P. Feener s chief scientific officer.
Article continues below

READ MORE KalVista Pharma appoints Andreas Maetzel as SVP

Dr. Feener has more than 27 years of research experience in vascular biology and diabetic complications, contributing to more than 80 scientific publications during his career.

Prior to taking his new role at KalVista, he was an Associate Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Vascular Cell Biology at the Joslin Diabetes Center, a research and clinical affiliate of Harvard Medical School.

Dr. Feener received his Ph.D. in Biochemistry from Boston University and completed postdoctoral training at the Joslin Center and Harvard Medical School.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy